Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Evoke Wealth LLC

Evoke Wealth LLC cut its position in shares of Mettler-Toledo International Inc. (NYSE:MTD) by 5.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 2,885 shares of the medical instruments supplier’s stock after selling 176 shares during the quarter. Evoke Wealth LLC’s holdings in Mettler-Toledo International were worth $3,530,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently modified their holdings of MTD. Axxcess Wealth Management LLC grew its stake in shares of Mettler-Toledo International by 6.7% in the 4th quarter. Axxcess Wealth Management LLC now owns 870 shares of the medical instruments supplier’s stock worth $1,065,000 after purchasing an additional 55 shares during the last quarter. Cibc World Markets Corp lifted its position in shares of Mettler-Toledo International by 13.0% during the 4th quarter. Cibc World Markets Corp now owns 3,315 shares of the medical instruments supplier’s stock valued at $4,056,000 after acquiring an additional 382 shares during the last quarter. Envestnet Portfolio Solutions Inc. grew its holdings in shares of Mettler-Toledo International by 5.8% in the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 513 shares of the medical instruments supplier’s stock worth $628,000 after acquiring an additional 28 shares during the last quarter. Frank Rimerman Advisors LLC raised its position in shares of Mettler-Toledo International by 7.4% during the fourth quarter. Frank Rimerman Advisors LLC now owns 408 shares of the medical instruments supplier’s stock worth $499,000 after purchasing an additional 28 shares during the period. Finally, Intact Investment Management Inc. purchased a new position in Mettler-Toledo International in the 4th quarter worth about $122,000. Institutional investors own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the business’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total transaction of $810,804.00. Following the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $8,108.04. The trade was a 99.01 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Christian Magloth sold 790 shares of Mettler-Toledo International stock in a transaction dated Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the sale, the insider now directly owns 734 shares in the company, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,234.56 on Tuesday. Mettler-Toledo International Inc. has a one year low of $1,142.91 and a one year high of $1,546.93. The company’s fifty day moving average price is $1,294.68 and its two-hundred day moving average price is $1,315.34. The company has a market capitalization of $25.82 billion, a price-to-earnings ratio of 30.46, a PEG ratio of 3.30 and a beta of 1.15.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 42.71 earnings per share for the current year.

Analyst Upgrades and Downgrades

MTD has been the topic of several research analyst reports. Wells Fargo & Company lifted their price objective on shares of Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, February 10th. Robert W. Baird upped their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating for the company. Evercore ISI upped their price target on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research note on Monday, February 10th. Finally, Citigroup reduced their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research report on Tuesday, March 4th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $1,380.50.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.